These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20802526)

  • 1. K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function.
    Alvarez-Moya B; López-Alcalá C; Drosten M; Bachs O; Agell N
    Oncogene; 2010 Nov; 29(44):5911-22. PubMed ID: 20802526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
    Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
    Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of H- and K-Ras in Raf-1 activation determines the role of calmodulin in MAPK signaling.
    Moretó J; Vidal-Quadras M; Pol A; Santos E; Grewal T; Enrich C; Tebar F
    Cell Signal; 2009 Dec; 21(12):1827-36. PubMed ID: 19666110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T; Karin M
    Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
    Matesic DF; Villio KN; Folse SL; Garcia EL; Cutler SJ; Cutler HG
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):741-54. PubMed ID: 16254733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin modulates H-Ras mediated Raf-1 activation.
    Moretó J; Lladó A; Vidal-Quadras M; Calvo M; Pol A; Enrich C; Tebar F
    Cell Signal; 2008 Jun; 20(6):1092-103. PubMed ID: 18356021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
    De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A
    Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
    He S; Dibas A; Yorio T; Prasanna G
    Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
    Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP
    Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol.
    Troppmair J; Bruder JT; App H; Cai H; Liptak L; Szeberényi J; Cooper GM; Rapp UR
    Oncogene; 1992 Sep; 7(9):1867-73. PubMed ID: 1386920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
    Chang ZL; Lin MQ; Wang MZ; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines.
    Liou JS; Chen JS; Faller DV
    J Cell Physiol; 2004 Feb; 198(2):277-94. PubMed ID: 14603530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K.
    Rosseland CM; Wierød L; Flinder LI; Oksvold MP; Skarpen E; Huitfeldt HS
    J Cell Physiol; 2008 Jun; 215(3):818-26. PubMed ID: 18163378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival.
    Cosentino C; Di Domenico M; Porcellini A; Cuozzo C; De Gregorio G; Santillo MR; Agnese S; Di Stasio R; Feliciello A; Migliaccio A; Avvedimento EV
    Oncogene; 2007 Mar; 26(14):2095-103. PubMed ID: 17016431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.